Pacific Biosciences of California Company Profile (NASDAQ:PACB)

Analyst Ratings

Consensus Ratings for Pacific Biosciences of California (NASDAQ:PACB) (?)
Ratings Breakdown: 2 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $12.06 (51.73% upside)

Analysts' Ratings History for Pacific Biosciences of California (NASDAQ:PACB)
Show:
DateFirmActionRatingPrice TargetActions
6/29/2016Cantor FitzgeraldReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2016CL KingInitiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/15/2016MKM PartnersInitiated CoverageNeutral$16.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2016First AnalysisInitiated CoverageOverweight$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016StephensReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016JPMorgan Chase & Co.Boost Price Target$10.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016Piper Jaffray Cos.DowngradeOverweight -> Neutral$9.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2015William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/27/2015Maxim GroupReiterated RatingBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for Pacific Biosciences of California (NASDAQ:PACB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016        
4/21/2016Q1($0.25)($0.23)$18.02 million$19.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2016Q4($0.02)($0.02)$36.96 million$36.28 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2015Q3($0.27)$0.02$15.84 million$13.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215($0.14)($0.16)$26.36 million$24.94 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q115($0.27)($0.27)$13.70 million$17.65 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2015Q414($0.26)($0.26)$14.90 million$16.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2014Q214($0.16)($0.13)$17.20 million$20.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2014Q114($0.15)($0.27)$11.39 million$11.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2014($0.28)($0.28)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2014Q413($0.27)($0.26)$9.13 million$9.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2013Q313($0.30)($0.31)$7.08 million$7.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q2 2013($0.35)($0.33)$6.09 million$6.04 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2013Q1 2013($0.37)($0.37)$4.28 million$5.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/5/2013Q4 2012($0.37)($0.39)$4.38 million$5.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2012($0.45)($0.41)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/26/2012($0.46)($0.40)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2012($0.47)($0.50)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/7/2012($0.50)($0.42)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2011($0.63)($0.42)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2011($0.67)($0.66)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/15/2011($0.91)($0.97)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Pacific Biosciences of California (NASDAQ:PACB)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.26)($0.26)($0.26)
Q2 20161($0.23)($0.23)($0.23)
Q3 20161($0.17)($0.17)($0.17)
Q4 20161($0.19)($0.19)($0.19)
Q1 20171($0.19)($0.19)($0.19)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Pacific Biosciences of California (NASDAQ:PACB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Pacific Biosciences of California (NASDAQ:PACB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
4/25/2016James Michael PhillipsSVPSell20,000$10.29$205,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Brian B DowVPBuy2,503$4.91$12,289.73View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Kevin P CorcoranSVPBuy2,816$4.91$13,826.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014William W EricsonDirectorBuy39,299$5.14$201,996.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2014William W EricsonDirectorBuy135,155$5.09$687,938.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2014William W EricsonDirectorBuy77,822$5.00$389,110.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014William W EricsonDirectorBuy29,435$4.93$145,114.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014William W EricsonDirectorBuy123,423$4.89$603,538.47View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2013Michael HunkapillerCEOBuy100,000$4.13$413,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/21/2013Michael HunkapillerCEOBuy200,000$3.61$722,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2012Michael HunkapillerCEOBuy154,100$1.75$269,675.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/29/2012Michael HunkapillerCEOBuy242,200$1.68$406,896.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2012Michael HunkapillerCEOBuy186,400$1.44$268,416.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2012Michael HunkapillerCEOBuy155,000$1.27$196,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/16/2012Michael HunkapillerCEOBuy262,300$1.16$304,268.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2012Michael HunkapillerCEOBuy400,000$1.75$700,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Pacific Biosciences of California (NASDAQ:PACB)
DateHeadline
07/18/16 01:09 PMETF’s with exposure to Pacific Biosciences of California, Inc. : July 18, 2016 -
07/16/16 05:13 PMPacific Biosciences of California, Inc. (NASDAQ:PACB)'s Growth Projection - RealistInvestor.com
07/16/16 08:58 AMPacific Biosciences of California Inc Realized Volatility Hits Elevated Level - CML News
07/14/16 09:18 AMPacific Biosciences of California, Inc. (NASDAQ:PACB) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/14/16 09:18 AMPacific Biosciences of California, Inc. Second Quarter 2016 Financial Results Call - ForexTV.com
07/13/16 06:04 PMAnalysts Observing Stocks: Depomed, Inc. (NASDAQ:DEPO) , Pacific Biosciences of California, Inc. (NASDAQ:PACB) - Street Updates
07/13/16 06:04 PMAnalyst's Noticeable Buzzers: Johnson & Johnson (NYSE:JNJ) , Pacific Biosciences of California, Inc. (NASDAQ:PACB) - Street Updates
07/09/16 05:06 PMPacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Update on Growth Forecast - RealistInvestor.com
07/09/16 08:52 AMInstitutional Investors Lead Shift in Pacific Biosciences Of California Inc (NASDAQ:PACB) Sentiment - Engelwood Daily
07/09/16 08:52 AMShares Finishing Down for the Week Pacific Biosciences of California, Inc. (NASDAQ:PACB) - Engelwood Daily
07/07/16 08:35 AMCan Pacific Biosciences of California, Inc. (NASDAQ:PACB) Improve on the Earnings Front? - Engelwood Daily
07/07/16 08:35 AMWere Analysts Bullish Pacific Biosciences of California (NASDAQ:PACB) This Week? - Engelwood Daily
07/06/16 10:22 AMShare Performance Recap for: Pacific Biosciences of California, Inc. (NASDAQ:PACB) - Press Telegraph
07/03/16 05:04 PMPacific Biosciences of California, Inc. (NASDAQ:PACB) Target Price Is $11.8 - RealistInvestor.com
07/01/16 05:45 PMPacific Biosciences of California, Inc. Stock Momentum Hits Weakness - CML News
07/01/16 05:45 PMStocks Movements Activity: Pacific Biosciences of California, Inc. (NASDAQ:PACB) , Skyline Medical Inc. (NASDAQ ... - Street Updates
07/01/16 05:45 PMShort Term Price Target on Pacific Biosciences of California (PACB) - Trade Calls
07/01/16 08:30 AMPacific Biosciences of California : Patent Issued for Arrays of Integrated Analytical Devices and Methods for Production (USPTO 9372308)
06/30/16 05:59 PMAnalyst Rating Update on Pacific Biosciences of California (PACB) - TheFounders Daily
06/30/16 11:26 AMETF’s with exposure to Pacific Biosciences of California, Inc. : June 30, 2016 -
06/29/16 05:39 PMStock Tracking Lower in Session: Pacific Biosciences of California, Inc. (NASDAQ:PACB) - Telanagana Press
06/28/16 12:34 PMPacific Biosciences of California, Inc. :PACB-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 -
06/28/16 10:32 AMCovering the Bases on Pacific Biosciences of California, Inc. (NASDAQ:PACB): Where is the Stock Going? - Press Telegraph
06/27/16 06:30 AMCoverage initiated on Pacific Biosciences by CL King -
06/24/16 08:20 AMLast Analysts Rating Review: Galena Biopharma, Inc. (NASDAQ:GALE) , Pacific Biosciences of California, Inc ... - Street Updates
06/24/16 08:20 AMHC Stocks Reports Analysis: Pacific Biosciences of California (NASDAQ:PACB), Envision Healthcare Holdings Inc ... - share market updates (press release)
06/24/16 07:50 AMCold Spring Harbor Laboratory Scientists Produce High-Quality Maize Transcriptome with PacBio SMRT Sequencing - [at noodls] - Friday, June 24, 2016 MENLO PARK, Calif., June 24, 2016 (GLOBE NEWSWIRE) - Improvements in maize breeding are required to feed a growing population and will depend on a more complete understanding of global ...
06/23/16 06:17 PMPacific Biosciences Of California, Inc. (NASDAQ:PACB) Current Analyst Ratings - Fiscal Standard
06/23/16 08:23 AMPacific Biosciences of California (NASDAQ:PACB) Analyst Rating Consensus - TheFounders Daily
06/17/16 11:15 AMPacific Biosciences of California, Inc. – Value Analysis (NASDAQ:PACB) : June 17, 2016 -
06/16/16 05:55 PMEarnings Analysis to see: ArcelorMittal (NYSE:MT), Pacific Biosciences of California, Inc. (NASDAQ:PACB) - Beacon Chronicle
06/16/16 09:56 AMAnalyst Recommended Stock: Pacific Biosciences of California, Inc. (NASDAQ:PACB) - News Oracle
06/16/16 09:56 AMInvestors Focused Movers: Pacific Biosciences of California, Inc. (NASDAQ:PACB) , Connecture, Inc. (NASDAQ:CNXR) - Street Updates
06/15/16 07:32 AMPacific Biosciences of California, Inc. breached its 50 day moving average in a Bearish Manner : PACB-US : June 15, 2016 -
06/11/16 05:53 PMPrice Target Update: Pacific Biosciences of California, Inc. (NASDAQ:PACB) - News Oracle
06/11/16 08:34 AMHC Stocks to Path: Pacific Biosciences of California (NASDAQ:PACB), Agios Pharmaceuticals Inc (NASDAQ:AGIO) - share market updates (press release)
06/10/16 08:43 AMComprehensive Report on: General Growth Properties, Inc (NYSE:GGP), Pacific Biosciences of California, Inc ... - Beacon Chronicle
06/09/16 06:05 PMStrong On High Volume: Pacific Biosciences Of California (PACB) - TheStreet.com
06/09/16 08:40 AMHC Stocks Analysis: Immunomedics, Inc. (NASDAQ:IMMU), Pacific Biosciences of California (NASDAQ:PACB) - share market updates (press release)
06/09/16 08:40 AMStocks Showing Movement: Restoration Hardware Holdings, Inc. (NYSE:RH), Pacific Biosciences of California, Inc ... - Beacon Chronicle
06/08/16 06:06 PMPACIFIC BIOSCIENCES OF CALIFORNIA INC. (NASDAQ:PACB) Financial Condition Compared to S&P 500 - CML News
06/08/16 08:42 AMPacific Biosciences of California Inc. (PACB) is Trading Lower on Unusual Volume for June 06 - Equities.com
06/07/16 05:54 PMHot Stock under Consideration: Pacific Biosciences of California, Inc. (NASDAQ:PACB) - News Oracle
06/06/16 05:39 PMTrending Stock Analysis: Pacific Biosciences of California, Inc. (NASDAQ:PACB) - News Oracle
06/06/16 05:39 PMStocks with Buy Rating: Pacific Biosciences of California, Inc. (NASDAQ:PACB), PulteGroup, Inc. (NYSE:PHM) - Beacon Chronicle
06/06/16 09:23 AMObserving Healthcare Stocks Update: Abbott Laboratories (NYSE:ABT) , Pacific Biosciences of California, Inc ... - Is stories
06/06/16 09:23 AMHC Stocks Movements to Focus: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Pacific Biosciences of California ... - share market updates (press release)
06/03/16 06:14 PMAnalysts Observing Stocks: Endo International plc (NASDAQ:ENDP) , Pacific Biosciences of California, Inc. (NASDAQ ... - Street Updates
06/03/16 06:14 PMPacific Biosciences of California, Inc. (NASDAQ:PACB) Stock Update & Estimates - Stock Tick Tock
06/03/16 06:14 PMStock's Earnings Activity: Pacific Biosciences of California, Inc. (NASDAQ:PACB), Halcon Resources Corporation ... - Beacon Chronicle

Social

About Pacific Biosciences of California

Pacific Biosciences of California logoPacific Biosciences of California Inc. designs, develops and manufactures the PacBio RS II Sequencing System to help scientists resolve genetically complex problems. Based on the Company's Single Molecule, Real-Time (SMRT) technology, its products enable de novo genome assembly to finish genomes in order to more fully identify, annotate and decipher genomic structures; full-length transcript analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms and find genes; targeted sequencing to more comprehensively characterize genetic variations; and DNA (deoxyribonucleic acid) base modification identification to help characterize epigenetic regulation and DNA damage. SMRT enables single molecule, real-time detection of biological processes. Based on its SMRT technology, the Company introduced the PacBio RS II System to address many of the limitations.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: PACB
  • CUSIP: 69404D10
Key Metrics:
  • Previous Close: $7.91
  • 50 Day Moving Average: $8.30
  • 200 Day Moving Average: $9.25
  • P/E Ratio: N/A
  • P/E Growth: -0.31
  • Market Cap: $692.99M
  • Beta: 3.03
  • Current Year EPS Consensus Estimate: $-0.84 EPS
  • Next Year EPS Consensus Estimate: $-0.67 EPS
Additional Links:
Pacific Biosciences of California (NASDAQ:PACB) Chart for Saturday, July, 23, 2016